Friday, July 10, 2026

pharma · Overweight and Obesity

Chengdu Di'ao Pharmaceutical

Chengdu Di'ao Pharmaceutical clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Chengdu, CN HQ
7 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Chengdu, CN
Employees
7
Programs
1
Drugs
0
Patents
0
Intelligence · Clinical Programs

Chengdu Di'ao Pharmaceutical projects

1 ClinicalTrials.gov programs sponsored by Chengdu Di'ao Pharmaceutical.

Chengdu Di'ao Pharmaceutical has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. DA-302168S

    Chendu DIAO Pharmaceutical Group CO., LTD.

    Overweight and Obesity

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Chengdu Di'ao Pharmaceutical have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.